Should adjuvant chemotherapy be used to treat breast cancer in elderly patients (>=70 years of age)?

被引:8
作者
Balducci, L
Extermann, M
Fentiman, I
Monfardini, S
Perrone, F
机构
[1] H. Lee Moffitt Cancer Center and Research Institute, 12902 Magnolia Drive, Tampa
关键词
D O I
10.1016/S0959-8049(97)00297-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:1720 / 1722
页数:3
相关论文
共 22 条
[11]   COSTS AND BENEFITS OF ADJUVANT THERAPY IN BREAST-CANCER - A QUALITY-ADJUSTED SURVIVAL ANALYSIS [J].
GOLDHIRSCH, A ;
GELBER, RD ;
SIMES, RJ ;
GLASZIOU, P ;
COATES, AS .
JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (01) :36-44
[12]  
JAYESIMI IA, 1995, J CLIN ONCOL, V13, P513
[13]   ADJUVANT RANDOMIZED TRIALS OF DOXORUBICIN CYCLOPHOSPHAMIDE VERSUS DOXORUBICIN CYCLOPHOSPHAMIDE TAMOXIFEN AND CMF CHEMOTHERAPY VERSUS TAMOXIFEN IN WOMEN WITH NODE-POSITIVE BREAST-CANCER [J].
KAUFMANN, M ;
JONAT, W ;
ABEL, U ;
HILFRICH, J ;
CAFFIER, H ;
KREIENBERG, R ;
TRAMS, G ;
BRUNNERT, K ;
SCHERMANN, J ;
KLEINE, W ;
MAHLKE, M ;
NEISES, M ;
STOSIEK, U ;
STIGLMAYER, R ;
SEEGER, F ;
LANGNICKEL, D ;
NAGEL, G ;
GAMPE, M ;
MAASS, H ;
KUBLI, F .
JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (03) :454-460
[14]  
Mansour E G, 1992, J Natl Cancer Inst Monogr, P97
[15]   RELATIONSHIP OF PATIENT AGE TO PATHOLOGICAL FEATURES OF THE TUMOR AND PROGNOSIS FOR PATIENTS WITH STAGE-I OR STAGE-II BREAST-CANCER [J].
NIXON, AJ ;
NEUBERG, D ;
HAYES, DF ;
GELMAN, R ;
CONNOLLY, JL ;
SCHNITT, S ;
ABNER, A ;
RECHT, A ;
VICINI, F ;
HARRIS, JR .
JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (05) :888-894
[16]  
PRITCHARD KI, 1994, P AN M AM SOC CLIN, V13, P65
[17]  
RIVKIN SE, 1984, RECENT RES CANCER, V96, P166
[18]   ADJUVANT CMFVP VERSUS TAMOXIFEN VERSUS CONCURRENT CMFVP AND TAMOXIFEN FOR POSTMENOPAUSAL, NODE-POSITIVE, AND ESTROGEN RECEPTOR-POSITIVE BREAST-CANCER PATIENTS - A SOUTHWEST-ONCOLOGY-GROUP STUDY [J].
RIVKIN, SE ;
GREEN, S ;
METCH, B ;
CRUZ, AB ;
ABELOFF, MD ;
JEWELL, WR ;
COSTANZI, JJ ;
FARRAR, WB ;
MINTON, JP ;
OSBORNE, CK .
JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (10) :2078-2085
[19]   THE EFFECT OF COMORBIDITY ON 3-YEAR SURVIVAL OF WOMEN WITH PRIMARY BREAST-CANCER [J].
SATARIANO, WA ;
RAGLAND, DR .
ANNALS OF INTERNAL MEDICINE, 1994, 120 (02) :104-110
[20]   6-YEAR RESULTS OF THE EASTERN COOPERATIVE ONCOLOGY GROUP TRIAL OF OBSERVATION VERSUS CMFP VERSUS CMFPT IN POSTMENOPAUSAL PATIENTS WITH NODE-POSITIVE BREAST-CANCER [J].
TAYLOR, SG ;
KNUIMAN, MW ;
SLEEPER, LA ;
OLSON, JE ;
TORMEY, DC ;
GILCHRIST, KW ;
FALKSON, G ;
ROSENTHAL, SN ;
CARBONE, PP ;
CUMMINGS, FJ .
JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (07) :879-889